Trial Profile
Characterization of the intrahepatic immune response of virally-suppressed chronic hepatitis B patients to treatment with GS-9620
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 10 Jul 2017
Price :
$35
*
At a glance
- Drugs Vesatolimod (Primary)
- Indications Hepatitis B
- Focus Pharmacodynamics; Therapeutic Use
- 10 Jul 2017 New trial record